Clinical Trial Update: Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease [Phase 4]

View source ↗

Summary

A phase 4 trial assessing the safety and efficacy of tegoprazan in patients with healed erosive reflux disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Reflux Disease

Drugs mentioned

• Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Erosive Reflux Disease | Phase 4 | Status: COMPLETED